Saturation at home for Interstitial Lung Disease

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Interstitial Lung DiseaseSaturation at home - Other
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial is testing whether taking saturation measurements at home has any real clinical benefit for patients with interstitial pulmonary diseases. Early results suggest that it may cause more anxiety and lead to more unnecessary doctor visits.

Eligible Conditions
  • Interstitial Lung Disease

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 5 Secondary · Reporting Duration: 1 year

1 year
Acute exacerbation
Anxiety and depression score
Dyspnea score
Energy expenditure
Health care use (phone calls, medical consultation)
Mortality
Physical activity level
Pulmonary function decline
Quality of life by questionnaire

Trial Safety

Safety Progress

1 of 3

Trial Design

2 Treatment Groups

Control Group
1 of 2
Intervention Group
1 of 2

Active Control

Experimental Treatment

100 Total Participants · 2 Treatment Groups

Primary Treatment: Saturation at home · No Placebo Group · N/A

Intervention Group
Other
Experimental Group · 1 Intervention: Saturation at home · Intervention Types: Other
Control GroupNoIntervention Group · 1 Intervention: Control Group · Intervention Types:

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 1 year

Who is running the clinical trial?

Fondation IUCPQOTHER
3 Previous Clinical Trials
190 Total Patients Enrolled
Laval UniversityLead Sponsor
391 Previous Clinical Trials
164,848 Total Patients Enrolled
Geneviève Dion, MDPrincipal InvestigatorInstitut universitaire de pneumologie et cardiologue de Québec - ULaval

Eligibility Criteria

Age 18+ · All Participants · 3 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you: